Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

Paul Y. Kwo, Fred Poordad, Armen Asatryan, Stanley Wang, David L. Wyles, Tarek Hassanein, Franco Felizarta, Mark S. Sulkowski, Edward Gane, Benedict Maliakkal, J. Scott Overcash, Stuart C. Gordon, Andrew J. Muir, Humberto Aguilar, Kosh Agarwal, Gregory J. Dore, Chih Wei Lin, Ran Liu, Sandra S. Lovell, Teresa I. NgJens Kort, Federico J. Mensa

Research output: Contribution to journalArticlepeer-review

253 Scopus citations

Fingerprint

Dive into the research topics of 'Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science